Genetics of Inflammatory Bowel Disease: Current Status and Future Directions

Overview

Journal Can J Gastroenterol

Specialty Gastroenterology

Date 2006 Oct 27

PMID 17066152

Citations 4

Authors

Thomas D Walters

Mark S Silverberg

Affiliations

Soon will be listed here.

Citing Articles

Genetics of ulcerative colitis: putting into perspective the incremental gains from Indian studies.

Juyal G, Sood A, Midha V, Thelma B J Genet. 2018; 97(5):1493-1507.

PMID: 30555100

Have genomic discoveries in inflammatory bowel disease translated into clinical progress?.

Weizman A, Silverberg M Curr Gastroenterol Rep. 2012; 14(2):139-45.

PMID: 22302508 DOI: 10.1007/s11894-012-0248-6.

Current view of the immunopathogenesis in inflammatory bowel disease and its implications for therapy.

Torres M, Rios A World J Gastroenterol. 2008; 14(13):1972-80.

PMID: 18395894 PMC: 2701515. DOI: 10.3748/wjg.14.1972.

Novel genetic markers in inflammatory bowel disease.

Rodriguez-Bores L, Fonseca G, Villeda M, Yamamoto-Furusho J World J Gastroenterol. 2007; 13(42):5560-70.

PMID: 17948929 PMC: 4172734. DOI: 10.3748/wjg.v13.i42.5560.

References

Brant S, Panhuysen C, Nicolae D, Reddy D, Bonen D, Karaliukas R . MDR1 Ala893 polymorphism is associated with inflammatory bowel disease. Am J Hum Genet. 2003; 73(6):1282-92. PMC: 1180394. DOI: 10.1086/379927. View

McGovern D, van Heel D, Negoro K, Ahmad T, Jewell D . Further evidence of IBD5/CARD15 (NOD2) epistasis in the susceptibility to ulcerative colitis. Am J Hum Genet. 2003; 73(6):1465-6. PMC: 1180410. DOI: 10.1086/379745. View

Glas J, Torok H, Schiemann U, Folwaczny C . MDR1 gene polymorphism in ulcerative colitis. Gastroenterology. 2004; 126(1):367. DOI: 10.1053/j.gastro.2003.08.045. View

Danze P, Colombel J, Jacquot S, Loste M, Heresbach D, Ategbo S . Association of HLA class II genes with susceptibility to Crohn's disease. Gut. 1996; 39(1):69-72. PMC: 1383234. DOI: 10.1136/gut.39.1.69. View

Trallori G, Palli D, Saieva C, Bardazzi G, Bonanomi A, DAlbasio G . A population-based study of inflammatory bowel disease in Florence over 15 years (1978-92). Scand J Gastroenterol. 1996; 31(9):892-9. DOI: 10.3109/00365529609051998. View

Parkes M, Satsangi J, Lathrop G, Bell J, Jewell D . Susceptibility loci in inflammatory bowel disease. Lancet. 1996; 348(9041):1588. DOI: 10.1016/S0140-6736(05)66204-6. View

Roussomoustakaki M, Satsangi J, Welsh K, Louis E, Fanning G, Targan S . Genetic markers may predict disease behavior in patients with ulcerative colitis. Gastroenterology. 1997; 112(6):1845-53. DOI: 10.1053/gast.1997.v112.pm9178675. View

Russel M, Pastoor C, Janssen K, van Deursen C, Muris J, van Wijlick E . Familial aggregation of inflammatory bowel disease: a population-based study in South Limburg, The Netherlands. The South Limburg IBD Study Group. Scand J Gastroenterol Suppl. 1997; 223:88-91. View

Satsangi J, Jewell D, Bell J . The genetics of inflammatory bowel disease. Gut. 1997; 40(5):572-4. PMC: 1027155. DOI: 10.1136/gut.40.5.572. View

10.

Loftus Jr E, Silverstein M, Sandborn W, Tremaine W, Harmsen W, Zinsmeister A . Crohn's disease in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival. Gastroenterology. 1998; 114(6):1161-8. DOI: 10.1016/s0016-5085(98)70421-4. View

11.

Ogunbi S, Ransom J, Sullivan K, Schoen B, Gold B . Inflammatory bowel disease in African-American children living in Georgia. J Pediatr. 1998; 133(1):103-7. DOI: 10.1016/s0022-3476(98)70187-8. View

12.

KALOW W, Tang B, Endrenyi L . Hypothesis: comparisons of inter- and intra-individual variations can substitute for twin studies in drug research. Pharmacogenetics. 1998; 8(4):283-9. DOI: 10.1097/00008571-199808000-00001. View

13.

Ahmad T, Satsangi J, McGovern D, Bunce M, Jewell D . Review article: the genetics of inflammatory bowel disease. Aliment Pharmacol Ther. 2001; 15(6):731-48. DOI: 10.1046/j.1365-2036.2001.00981.x. View

14.

Rioux J, Silverberg M, Daly M, Steinhart A, McLeod R, Griffiths A . Genomewide search in Canadian families with inflammatory bowel disease reveals two novel susceptibility loci. Am J Hum Genet. 2000; 66(6):1863-70. PMC: 1378042. DOI: 10.1086/302913. View

15.

Inoue N, Tamura K, Kinouchi Y, Fukuda Y, Takahashi S, Ogura Y . Lack of common NOD2 variants in Japanese patients with Crohn's disease. Gastroenterology. 2002; 123(1):86-91. DOI: 10.1053/gast.2002.34155. View

16.

Abreu M, Taylor K, Lin Y, Hang T, Gaiennie J, Landers C . Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn's disease. Gastroenterology. 2002; 123(3):679-88. DOI: 10.1053/gast.2002.35393. View

17.

Orchard T, Chua C, Ahmad T, Cheng H, Welsh K, Jewell D . Uveitis and erythema nodosum in inflammatory bowel disease: clinical features and the role of HLA genes. Gastroenterology. 2002; 123(3):714-8. DOI: 10.1053/gast.2002.35396. View

18.

Yamazaki K, Takazoe M, Tanaka T, Kazumori T, Nakamura Y . Absence of mutation in the NOD2/CARD15 gene among 483 Japanese patients with Crohn's disease. J Hum Genet. 2002; 47(9):469-72. DOI: 10.1007/s100380200067. View

19.

Zhou Z, Lin X, Akolkar P, Levine J, Katz S, Silver J . Variation at NOD2/CARD15 in familial and sporadic cases of Crohn's disease in the Ashkenazi Jewish population. Am J Gastroenterol. 2002; 97(12):3095-101. DOI: 10.1111/j.1572-0241.2002.07105.x. View

20.

Yamamoto-Furusho J, Uscanga L, Vargas-Alarcon G, Ruiz-Morales J, Higuera L, Cutino T . Clinical and genetic heterogeneity in Mexican patients with ulcerative colitis. Hum Immunol. 2003; 64(1):119-23. DOI: 10.1016/s0198-8859(02)00772-3. View